Glass House Brands (GLAS) Current Leases (2020 - 2026)
Glass House Brands' (GLAS) quarterly Current Leases came in at $1.3 million in Q1 2026, down 11.96% year-on-year from $1.5 million in Q1 2025, and up 16.76% on a QoQ basis from $1.1 million in Q4 2025.
Glass House Brands (GLAS) Current Leases (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.
- On a quarterly basis, Current Leases fell 11.96% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 11.96% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, up 25.53% from the prior year.
- Current Leases for Q1 2026 stood at $1.3 million, up from $1.1 million in the prior quarter.
- Over the last five years, Current Leases for GLAS reached as high as $1.6 million in Q3 2024 and fell as low as $66790.0 in Q4 2022.
- Historically, Current Leases has averaged $1.0 million across 5 years, with a median of $1.1 million in 2023.
- Across the five-year window, Current Leases plunged 99.93% in 2022 and surged 479.43% in 2023, its largest moves.
- Year by year, Current Leases stood at $66790.0 in 2022, then jumped by 479.43% to $387000.0 in 2023, then soared by 129.72% to $889000.0 in 2024, then grew by 25.53% to $1.1 million in 2025, then grew by 16.76% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $1.3 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 170,000.00 |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 889,000.00 |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 387,000.00 |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 66,790.00 |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 561,127.00 |
| Mar 31, 2022 | 286,457.00 |
| Dec 31, 2021 | 269,154.00 |
| Sep 30, 2021 | 219,114.00 |
| Mar 31, 2021 | 401.23 Mn |